
The acquisition brings Gallant’s experimental stem cell treatments for feline chronic gingivostomatitis and osteoarthritis in dogs and cats into Dechra’s portfolio.
Here's a sneak peek at this week's industry news.
With Memorial Day just days away, we remain dedicated to providing you with the latest veterinary news right at your fingertips.
This week we will be posting a wide variety of content including:
Stay tuned on dvm360.com for our most recent coverage of the veterinary industry.




